Micro cap research
Select micro cap research reports on companies we feel have the potential for success in resources, medtech and more.
May 2024
Control Bionics
Medtech Micro Cap
Control Bionics Limited (ASX: CBL) is an Australian medical device company specialising in innovative electromyography (EMG) solutions for assistive communication, mobility, and data measurement. Since its IPO in December 2020, the company has prioritised expanding its core business, which continues to grow organically. However, recent innovations have opened new avenues for growth.
With its extensive experience in commercialisation, patented world- class technology, and regulatory approvals across multiple jurisdictions, including the US, CBL is primed for expanded global reach. Bolstered by a strong pipeline of new products and diverse growth prospects, Lynx Advisors views CBL as an attractive investment opportunity.
sign up